Optimizing bevacizumab dosing in first-line ovarian cancer treatment: the PGOG-ov1 trial

Related articles

1. A Phase I Dose-Escalation Study of Lobaplatin Combined with Paclitaxel in Platinum-Sensitive Recurrent Ovarian Epithelial Carcinoma: Safety, Tolerability, and Preliminary Efficacy Analysis

   This article has 7 authors:

   1. Dongling Zou
   2. Yi Gong
   3. Yingjie Yang
   4. Lifang Ma
   5. Li Yuan
   6. Jiaying Bai
   7. Qi Zhou

2. Toxicity and Outcomes of the KEYNOTE-522 Chemo-immunotherapy Regimen in Non-Metastatic Triple-negative Breast Cancer," for consideration for publication in the

   This article has 16 authors:

   1. Lina M. Adwer
   2. Mackenzie Jones
   3. Kelsey R. Tieken
   4. Sara B. Cartwright
   5. Heng Jiang
   6. Lynette M. Smith
   7. Jiani Zhang
   8. Shivani Modi
   9. Samia Asif
   10. Meghana Kesireddy
   11. Amulya Yellala
   12. Andrew Wahl
   13. Janelle-Cheri Millen
   14. Jessica Maxwell
   15. Jairam Krishnamurthy
   16. Juan A. Santamaria-Barria

3. A Study on the Efficacy of Immune Checkpoint Inhibitors Combined with Chemotherapy in Patients with Oligometastatic Driver Gene-Negative Non-Small Cell Lung Cancer Undergoing Radiotherapy

   This article has 10 authors:

   1. Yang Liu
   2. Lingxiao Xie
   3. Jiaoyue Qu
   4. Quan Pan
   5. Zhao Yu
   6. Yin Yuan
   7. Chunyu Chang
   8. Hao Jiang
   9. Yuexin Yang
   10. Gengming Wang at